← Leaderboards
Gregory John Johnson
Jsk Therapeutics, Inc.
$87,519
Attributed
$262,556
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $142.8K · FY2010–14$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$262,556 · 1
By mechanism
R44$262,556 · 1
Top collaborators
- Thomas Preston Kennedy2 shared
- Paul J Shami2 shared
Most similar at Jsk Therapeutics, Inc.
Same institution · by research overlap
- Joseph Felix Nowoslawski$1,998,606
- Sudhir Sahasrabudhe$309,189
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAnimalsAnticancer ActivityAntineoplastic AgentsAqueousBacteriaBaseBone MarrowBone Marrow CellsCancer CellCancer PatientCancer TherapyCanis FamiliarisCapital FinancingCardiovascular SystemCellsChemistryChromosome AbnormalityChronicCitiesClinical TrialsCollaborationsCollegeAchievement